PharVision Advisers’s Corsair Gaming CRSR Stock Holding History

PharVision Advisers’s Portfolio CRSR Stock Details CRSR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19,400	Closed	-$128K	–	321
2024 Q4	$128K	Buy	+19,400	New	+$135K	0.11%	359

Other funds holding CRSR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PharVision Advisers's CRSR Position: Q1 2025 in Review

PharVision Advisers sold out of Corsair Gaming (CRSR) in Q1 2025, closing a stake of 19,400 shares — an estimated $128K sold.

PharVision Advisers first reported a position in CRSR in Q4 2024 and held it in 1 quarter. The position peaked at $128K in Q4 2024. 172 funds tracked by Wall St. Rank hold CRSR as of Q1 2025.

PharVision Advisers reported no remaining Corsair Gaming position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 19,400 Corsair Gaming shares in Q1 2025, an estimated $128K.
PharVision Advisers first reported a position in Corsair Gaming in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Corsair Gaming position peaked at $128K in Q4 2024.
172 funds tracked by Wall St. Rank held Corsair Gaming as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.